Chemoimmunotherapy, radiation therapy, or targeted treatments can help treat follicular lymphoma. Doctors may also recommend active surveillance.

Y-mAbs Therapeutics, Inc. has announced the presentation of its GD2-SADA pretargeted radioimmunotherapy as part of a trial in progress at the Advances in Neuroblastoma Research Meeting in ...

Y-mAbs announces first patient dosed in Phase 1 trial of CD38-SADA pre-targeted radioimmunotherapy for relapsed non-Hodgkin lymphoma.

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma ...

Molecular Imaging and Carbonic Anhydrase IX-targeted Radioimmunotherapy in Clear Cell Renal Cell Carcinoma ...

The targeted delivery of radionucleotides into tumors, known as radioimmunotherapy (RIT), has proven effective mainly in hematological cancer treatment, but its usefulness in solid tumors needs ...

The agents, sequence, dose, fractionation, and irradiated sites required further exploration. What are some of the unique follow-up needs for long-term NSCLC survivors after radioimmunotherapy?

Selective Personalized RadioImmunotherapy for Locally Advanced Non–Small-Cell Lung Cancer Trial (SPRINT) – An ASCO Reading Room selection March 8, 2024 • 2 min read ...